Control | Isocaloric | Ethanol | |||||||
---|---|---|---|---|---|---|---|---|---|
Emax | pD2 | Emax | pD2 | Emax | pD2 | ||||
g | g | g | |||||||
BQ-123 | |||||||||
0.001 μM | 0.45 ± 0.04 (6) | 8.75 ± 0.06 | 0.39 ± 0.03 (6) | 8.69 ± 0.03 | 0.55 ± 0.02 (6)a | 8.68 ± 0.01 | |||
0.01 μM | 0.46 ± 0.04 (6) | 8.68 ± 0.04 | 0.41 ± 0.04 (6) | 8.60 ± 0.05 | 0.56 ± 0.03 (6)a | 8.64 ± 0.03 | |||
0.3 μM | 0.35 ± 0.05 (6) | 8.22 ± 0.11 | 0.34 ± 0.03 (6) | 8.15 ± 0.09b | 0.51 ± 0.04 (6)a | 8.32 ± 0.04b,c | |||
1.0 μM | 0.26 ± 0.06 (6)b | 7.93 ± 0.10b,c,d | 0.23 ± 0.08 (6)b,c,d | 7.94 ± 0.03b,d,e | 0.43 ± 0.06 (6)a | 7.92 ± 0.05b,c,d | |||
3.0 μM | 0.13 ± 0.03 (6)b,d | 7.94 ± 0.10b,c,d | 0.13 ± 0.04 (6)b,c,d | 8.12 ± 0.20b | 0.22 ± 0.06 (6)b,d | 7.71 ± 0.07b,c,d | |||
5.0 μM | 0.19 ± 0.03 (6)b,d | 7.78 ± 0.06b,c,d | 0.13 ± 0.06 (6)b,c,d | 7.73 ± 0.03b,c,d | 0.31 ± 0.04 (6)a,b,d | 7.76 ± 0.10b,c,d | |||
BQ-788 | |||||||||
Absent | 0.44 ± 0.04 (8) | 8.75 ± 0.12 | 0.46 ± 0.03 (9) | 8.81 ± 0.08 | 0.58 ± 0.04 (12)a | 8.79 ± 0.05 | |||
0.1 M | 0.42 ± 0.03 (6) | 8.82 ± 0.06 | 0.45 ± 0.03 (5) | 8.86 ± 0.03 | 0.47 ± 0.05 (7) | 8.66 ± 0.02 | |||
0.3 M | 0.43 ± 0.06 (6) | 8.70 ± 0.08 | 0.49 ± 0.04 (5) | 8.70 ± 0.13 | 0.49 ± 0.05 (7) | 8.66 ± 0.04 | |||
1.0 M | 0.26 ± 0.02 (6)b,c | 8.45 ± 0.02b,e | 0.29 ± 0.02 (5)b,e | 8.67 ± 0.09 | 0.31 ± 0.05 (7)b,e | 8.37 ± 0.10b,e | |||
3.0 M | 0.29 ± 0.07 (6)b,e | 8.16 ± 0.11b,e | 0.33 ± 0.03 (5)b,e | 8.45 ± 0.08b,e | 0.32 ± 0.05 (7)b,e | 8.24 ± 0.07b,e |
↵ a Compared with control and isocaloric groups
↵ b Compared with the respective group in the absence of the antagonist (BQ-123 or BQ-788)
↵ c Compared with the respective group in the presence of BQ-123, 0.001 and 0.01 μM
↵ d Compared with the respective group in the presence of BQ-123, 0.001, 0.01, and 0.3 μM
↵ e Compared with the respective group in the presence of BQ-788, 0.1 and 0.3 μM